The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy-Reference-Cited by-同舟云学术

The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy

Published:2022-08 Issue:3 Volume:1 Page:100064
ISSN:2772-963X
Container-title:JACC: Advances
language:en
Short-container-title:JACC: Advances

Author:

Sarma Amy A.,Aggarwal Niti R.,Briller Joan E.,Davis Melinda,Economy Katherine E.,Hameed Afshan B.,Januzzi James L.,Lindley Kathryn J.,Mattina Deirdre J.,McBay Brandon,Quesada Odayme^ORCID,Scott Nandita S.

Publisher

Elsevier BV

Reference72 articles.

1. The importance of cardiovascular risk assessment and pregnancy heart team in the management of cardiovascular disease in pregnancy;Sharma;Cardiol Clin,2021

2. Pregnancy in women with congenital heart disease;Yucel;Curr Treat Options Cardiovasc Med,2017

3. Pregnancy outcomes in women with heart disease: the CARPREG II study;Silversides;J Am Coll Cardiol,2018

4. Natriuretic peptides in heart failure and acute coronary syndrome;Gaggin;Clin Lab Med,2014

5. Longitudinal changes in the B-type natriuretic peptide levels in normal pregnancy and postpartum;Hameed;Clin Cardiol,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obstetric anesthesia management of dilated cardiomyopathies and heart failure: a narrative review;International Journal of Obstetric Anesthesia;2024-11

2. Feto‐maternal indicators of cardiac dysfunction as a justification for the cardiac origins for pre‐eclampsia;International Journal of Gynecology & Obstetrics;2024-07-07

3. Intrapartum trends of NT-proBNP and hs-cTnT in patients with severe features of preeclampsia;Pregnancy Hypertension;2024-03

4. Cardio-Obstetrics Team-Based Management of a Pregnant Patient With Severe Bioprosthetic Aortic Valve Disease;JACC: Case Reports;2024-02

5. Biomarkers in Peripartum Cardiomyopathy—What We Know and What Is Still to Be Found;Biomolecules;2024-01-12